-
Over-the-counter supplement could prevent heart disease in type 2 diabetes patients
A cheap over-the-counter supplement could hold the key to preventing heart failure in people with Type 2 diabetes, according to... Read more -
Urinary tract infection drug recalled
Three lots of a drug designed to treat various urinary tract infections have been recalled because the white round tablets... Read more -
Zebrafish model for an ultra-rare genetic disease reveals two promising drug candidates
Can a small fish help identify possible treatments for an ultra-rare inherited disease found in an Alabama boy? The genetic... Read more -
New approach reverses opioid overdoses more safely, rat study shows
Opioid overdoses are a major public health issue in the U.S., killing tens of thousands of people every year. The... Read more -
RFK Jr. calls for a review of abortion pill mifepristone
U.S. Health and Human Services Secretary Robert F. Kennedy Jr. has ordered a fresh safety review of mifepristone, a drug... Read more -
Biweekly dose of TAS-102 reduces toxicity and remains effective for treatment of colorectal cancer, says study
Patients with metastatic colorectal cancer who were treated with a biweekly dose of trifluridine-tipiracil (TAS-102) saw similar treatment effectiveness and... Read more -
Cancer treatments should be licensed for all ages, oncologists say
Recent advances have resulted in highly effective "tissue-agnostic" drugs that treat cancers based on their molecular markers rather than their... Read more -
Q&A: Long-term success of GLP-1 therapies hinges on more than just a prescription
GLP-1 (glucagon-like peptide-1) therapies can be powerful tools in managing obesity, with patients taking these medications seeing weight reductions of... Read more -
Long-term data show sustained efficacy and safety of zigakibart in patients with IgA nephropathy
New 100-week data from the ongoing Phase I/II study of zigakibart, an investigational anti-APRIL monoclonal antibody, reinforce its potential as... Read more -
Diabetes drug shows benefits for patients with liver disease
The sodium glucose cotransporter 2 (SGLT-2) inhibitor drug dapagliflozin, widely used to treat type 2 diabetes, also shows improvements for... Read more -
P2Y12 drugs may be better than aspirin to prevent heart attack and stroke in patients with coronary artery disease
Giving a P2Y12 inhibitor anti-clotting drug to patients with coronary artery disease is associated with lower rates of cardiovascular death,... Read more -
Q&A: How mpox research is helping scientists prepare for a new pandemic
The U.S. saw more than 20,000 mpox cases and nearly six dozen deaths during the 2022 global mpox outbreak. San... Read more -
Cholesterol-lowering drugs have no antidepressive effect, study shows
Lipid-lowering medicines, known as statins, are prescribed in cases of high cholesterol levels, to reduce the risk of atherosclerosis, heart... Read more -
New book details the good, bad and unexpected of ibuprofen
What you don't know about ibuprofen, one of the world's most popular painkillers, could well fill a book—and that book... Read more -
Asthma drug could help to treat a rare neurological disorder
The asthma medication theophylline is a suitable drug for treating the rare neurological disorder ADCY5-related dyskinesia, according to a new... Read more
